Cargando…
Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694521/ https://www.ncbi.nlm.nih.gov/pubmed/28466377 http://dx.doi.org/10.1007/s10637-017-0471-y |
_version_ | 1783280150397321216 |
---|---|
author | Mamesaya, Nobuaki Kenmotsu, Hirotsugu Takahashi, Toshiaki |
author_facet | Mamesaya, Nobuaki Kenmotsu, Hirotsugu Takahashi, Toshiaki |
author_sort | Mamesaya, Nobuaki |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5694521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-56945212017-11-30 Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab Mamesaya, Nobuaki Kenmotsu, Hirotsugu Takahashi, Toshiaki Invest New Drugs Short Report Springer US 2017-05-02 2017 /pmc/articles/PMC5694521/ /pubmed/28466377 http://dx.doi.org/10.1007/s10637-017-0471-y Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Short Report Mamesaya, Nobuaki Kenmotsu, Hirotsugu Takahashi, Toshiaki Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab |
title | Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab |
title_full | Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab |
title_fullStr | Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab |
title_full_unstemmed | Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab |
title_short | Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab |
title_sort | successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694521/ https://www.ncbi.nlm.nih.gov/pubmed/28466377 http://dx.doi.org/10.1007/s10637-017-0471-y |
work_keys_str_mv | AT mamesayanobuaki successfulosimertinibrechallengeinapatientwithadvancednonsmallcelllungcancerfollowingosimertinibinducedinterstitiallungdiseaseaftertreatmentwithnivolumab AT kenmotsuhirotsugu successfulosimertinibrechallengeinapatientwithadvancednonsmallcelllungcancerfollowingosimertinibinducedinterstitiallungdiseaseaftertreatmentwithnivolumab AT takahashitoshiaki successfulosimertinibrechallengeinapatientwithadvancednonsmallcelllungcancerfollowingosimertinibinducedinterstitiallungdiseaseaftertreatmentwithnivolumab |